<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Rapid Micro Biosystems Inc — News on 6ix</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc</link>
<description>Latest news and press releases for Rapid Micro Biosystems Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Thu, 12 Mar 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/rapid-micro-biosystems-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835b9db78dffbe2df115a1b.webp</url>
<title>Rapid Micro Biosystems Inc</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc</link>
</image>
<item>
<title>Rapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® Platform</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-follow-on-multi-system-order-from-samsung-biologics-to-expand-deployment-of-growth-directr-platform</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-follow-on-multi-system-order-from-samsung-biologics-to-expand-deployment-of-growth-directr-platform</guid>
<pubDate>Thu, 12 Mar 2026 04:00:00 GMT</pubDate>
<description>Companies deepen partnership to advance automated, integrated microbiology quality control LEXINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro</description>
</item>
<item>
<title>Rapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare Forum</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-to-participate-in-keybanc-capital-markets-healthcare-forum</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-to-participate-in-keybanc-capital-markets-healthcare-forum</guid>
<pubDate>Tue, 10 Mar 2026 20:45:00 GMT</pubDate>
<description>LEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the KeyBanc Capital Markets Healthcare Forum. The Company is scheduled to participate in a virtual question and answer session with the host analyst</description>
</item>
<item>
<title>Rapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care Conference</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-to-present-at-td-cowen-46th-annual-health-care-conference</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-to-present-at-td-cowen-46th-annual-health-care-conference</guid>
<pubDate>Thu, 26 Feb 2026 21:15:00 GMT</pubDate>
<description>LEXINGTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the TD Cowen 46th Annual Health Care Conference in Boston, MA. The Company is scheduled to present on Tuesday, March 3 at 10:30 a.m. Eastern Time. A live</description>
</item>
<item>
<title>Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-12-2026</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-to-announce-fourth-quarter-and-full-year-2025-financial-results-on-march-12-2026</guid>
<pubDate>Tue, 24 Feb 2026 21:15:00 GMT</pubDate>
<description>LEXINGTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2025 financial results prior to the market open on Thursday, March 12, 2026. In conjunction with the release, the Company’s management team will host a webcast c</description>
</item>
<item>
<title>Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-inducement-211500208</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-inducement-211500208</guid>
<pubDate>Thu, 12 Feb 2026 21:15:00 GMT</pubDate>
<description>LEXINGTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on February 2, 2026, of an aggregate of 205,000 restricted stock units (“RSUs”) of the Company’s Class A common stock (“Common Stock”) and non-qualified stock options to purcha</description>
</item>
<item>
<title>Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-record-211500071</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-record-211500071</guid>
<pubDate>Tue, 13 Jan 2026 21:15:00 GMT</pubDate>
<description>Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% compared to the prior-year period.Received record multi-system order in the fourth quarter from an existing Top 20 global biopharma customer to automate global manufacturing network.Full year 2025 total revenue expected to be approximately $33.6 million, representing growth of approximately 20% compared to the prior year. LEXINGTON, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Rapid</description>
</item>
<item>
<title>Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-present-44th-140000491</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-present-44th-140000491</guid>
<pubDate>Wed, 07 Jan 2026 14:00:00 GMT</pubDate>
<description>LEXINGTON, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The Company is scheduled to present on Thursday, January 15, 2026, at 2:15 p.m. Ea</description>
</item>
<item>
<title>Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-third-110000045</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-third-110000045</guid>
<pubDate>Fri, 07 Nov 2025 11:00:00 GMT</pubDate>
<description>Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter 2025 recurring revenue, which includes consumables and annual service contracts, increased 32% compared to the third quarter of 2024 driven by record consumable revenue. Reports third quarter gross margin of 9%, representing a 70-basis point improvement compared to the third quarter of 2024.Announces record multi-system order from an existing Top 20 global biophar</description>
</item>
<item>
<title>Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-participate-stifel-204500790</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-participate-stifel-204500790</guid>
<pubDate>Thu, 30 Oct 2025 20:45:00 GMT</pubDate>
<description>LEXINGTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2025 Healthcare Conference in New York, NY. Company management is scheduled to participate in a 30-minute question-and-answer session with</description>
</item>
<item>
<title>Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announce-third-210500388</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announce-third-210500388</guid>
<pubDate>Tue, 28 Oct 2025 21:05:00 GMT</pubDate>
<description>LEXINGTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2025 financial results prior to the market open on Friday, November 7, 2025. In conjunction with the release, the Company’s management team will host a webcast conference call</description>
</item>
<item>
<title>Trinity Capital Inc. Provides $45 Million in Growth Capital to Rapid Micro Biosystems, Modernizing Healthcare Industry Practices</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/trinity-capital-inc-provides-dollar45-million-in-growth-capital-to-rapid-micro-biosystems-modernizing-healthcare-industry-practices</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/trinity-capital-inc-provides-dollar45-million-in-growth-capital-to-rapid-micro-biosystems-modernizing-healthcare-industry-practices</guid>
<pubDate>Mon, 22 Sep 2025 12:00:00 GMT</pubDate>
<description>Trinity Capital Inc. (Nasdaq: TRIN) (the "Company"), a leading alternative asset manager, today announced the commitment of $45 million in growth capital to Rapid Micro Biosystems (Nasdaq: RPID) ("Rapid Micro"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products.</description>
</item>
<item>
<title>Rapid Micro Biosystems to Present at the H.C. Wainwright 27th Annual Global Investment Conference</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-present-h-204500288</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-present-h-204500288</guid>
<pubDate>Tue, 02 Sep 2025 20:45:00 GMT</pubDate>
<description>LEXINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the H.C.Wainwright 27th Annual Global Investment Conference in New York, NY. The Company is scheduled to present on Tuesday, September 9, 2025, at 11:00</description>
</item>
<item>
<title>Rapid Micro Biosystems Reports Second Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-second-103100729</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-second-103100729</guid>
<pubDate>Tue, 12 Aug 2025 10:31:00 GMT</pubDate>
<description>Reports second quarter 2025 total revenue of $7.3 million, representing 10% growth compared to the second quarter of 2024. Second quarter 2025 recurring revenue increased 15% compared to the second quarter of 2024. Reports second quarter gross margin of 4%, representing a seven-percentage point improvement compared to the second quarter of 2024. Enters into five-year, $45 million term loan facility with $20 million funded at close. Reaffirms full-year 2025 total revenue guidance of at least $32.</description>
</item>
<item>
<title>Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-enters-five-103000505</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-enters-five-103000505</guid>
<pubDate>Tue, 12 Aug 2025 10:30:00 GMT</pubDate>
<description>$20 million drawn down at closing, with access to up to an additional $25 million Strengthens Company’s financial position and reinforces ability to achieve positive cash flow LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today anno</description>
</item>
<item>
<title>Rapid Micro Biosystems to Announce Second Quarter 2025 Financial Results on August 12, 2025</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announce-second-201500400</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announce-second-201500400</guid>
<pubDate>Thu, 31 Jul 2025 20:15:00 GMT</pubDate>
<description>LEXINGTON, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2025 financial results prior to the market open on Tuesday, August 12, 2025. In conjunction with the release, the Company’s management team will host a webcast conference call</description>
</item>
<item>
<title>Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-appointment-130000735</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-appointment-130000735</guid>
<pubDate>Tue, 27 May 2025 13:00:00 GMT</pubDate>
<description>LEXINGTON, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, is pleased to welcome Dr. Dafni Bika to the Company’s Board of Directors (the “Board”). “We are extremely pleased to welcome Dr. Bika to our Board of Directors,” said Robert Spignesi, Pre</description>
</item>
<item>
<title>Rapid Micro Biosystems Reports First Quarter 2025 Financial Results</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-first-110000496</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-first-110000496</guid>
<pubDate>Fri, 09 May 2025 11:00:00 GMT</pubDate>
<description>Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“Mil</description>
</item>
<item>
<title>Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announce-first-201500065</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announce-first-201500065</guid>
<pubDate>Thu, 24 Apr 2025 20:15:00 GMT</pubDate>
<description>LEXINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2025 financial results prior to the market open on Friday, May 9, 2025. In conjunction with the release, the Company’s management team will host a webcast conference call at 8</description>
</item>
<item>
<title>Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-fourth-113000063</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-reports-fourth-113000063</guid>
<pubDate>Fri, 28 Feb 2025 11:30:00 GMT</pubDate>
<description>Reports record fourth quarter 2024 total revenue of $8.2 million, representing 30% growth compared to fourth quarter 2023; recurring revenue increased by 27% compared to the fourth quarter of 2023.Announces full year 2024 total revenue of $28.1 million, representing 25% growth compared to 2023; recurring revenue increase by 14% compared to 2023.Reports record fourth quarter gross margin of 12%, representing a 15-percentage point improvement over the fourth quarter of 2023; full year 2024 gross m</description>
</item>
<item>
<title>Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany</title>
<link>https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-global-211500383</link>
<guid isPermaLink="true">https://6ix.com/company/rapid-micro-biosystems-inc/news/rapid-micro-biosystems-announces-global-211500383</guid>
<pubDate>Thu, 27 Feb 2025 21:15:00 GMT</pubDate>
<description>Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for collaboration on supply chain efficiencies, services, and joint product development.LEXINGTON, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of h</description>
</item>
</channel>
</rss>